O	O	O	0	10	Reversible	Reversible	B-NP	JJ	O	2	NMOD	O
O	O	O	11	26	differentiation	differentiation	I-NP	NN	O	0	ROOT	O
O	O	O	27	29	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	30	35	human	human	B-NP	JJ	B-cell_line	8	NMOD	B-cell_line
O	O	O	36	47	monoblastic	monoblastic	I-NP	JJ	I-cell_line	8	NMOD	I-cell_line
O	O	O	48	56	leukemia	leukemia	I-NP	NN	I-cell_line	8	NMOD	I-cell_line
O	O	O	57	61	U937	U937	I-NP	NN	I-cell_line	8	NMOD	I-cell_line
O	O	O	62	67	cells	cell	I-NP	NNS	I-cell_line	3	PMOD	I-cell_line
O	O	O	68	70	by	by	B-PP	IN	O	2	NMOD	O
O	O	O	71	73	ML	ML	B-NP	NN	O	15	NMOD	O
O	O	O	73	74	-	-	O	HYPH	O	15	P	O
O	O	O	74	75	9	9	B-NP	CD	O	15	NMOD	O
O	O	O	75	76	,	,	O	,	O	15	P	O
O	O	O	77	79	an	an	B-NP	DT	O	15	NMOD	O
O	O	O	80	89	inhibitor	inhibitor	I-NP	NN	O	9	PMOD	O
O	O	O	90	92	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	93	99	myosin	myosin	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	100	105	light	light	I-NP	JJ	I-protein	20	NMOD	I-protein
O	O	O	106	111	chain	chain	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	O	112	118	kinase	kinase	I-NP	NN	I-protein	16	PMOD	I-protein
O	O	O	118	119	.	.	O	.	O	2	P	O

O	O	O	121	126	Human	Human	B-NP	JJ	B-cell_line	5	NMOD	B-cell_line
O	O	O	127	138	monoblastic	monoblastic	I-NP	JJ	I-cell_line	5	NMOD	I-cell_line
O	O	O	139	147	leukemia	leukemia	I-NP	NN	I-cell_line	5	NMOD	I-cell_line
O	O	O	148	152	U937	U937	I-NP	NN	I-cell_line	5	NMOD	I-cell_line
O	O	O	153	158	cells	cell	I-NP	NNS	I-cell_line	6	SUB	I-cell_line
O	O	O	159	162	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	163	170	induced	induce	I-VP	VBN	O	6	VC	O
O	O	O	171	173	to	to	I-VP	TO	O	9	VMOD	O
O	O	O	174	187	differentiate	differentiate	I-VP	VB	O	7	VMOD	O
O	O	O	188	192	into	into	B-PP	IN	O	9	VMOD	O
O	O	O	193	202	monocytes	monocyte	B-NP	NNS	B-cell_type	13	NMOD	B-cell_type
O	O	O	203	206	and	and	O	CC	O	13	NMOD	O
O	O	O	207	218	macrophages	macrophage	B-NP	NNS	B-cell_type	10	PMOD	B-cell_type
O	O	O	219	221	by	by	B-PP	IN	O	7	VMOD	O
O	O	O	222	229	various	various	B-NP	JJ	O	16	NMOD	O
O	O	O	230	236	agents	agent	I-NP	NNS	O	14	PMOD	O
O	O	O	236	237	.	.	O	.	O	6	P	O

O	O	O	238	240	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	241	245	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	246	251	shown	show	I-VP	VBN	O	2	VC	O
O	O	O	252	256	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	257	258	1	1	B-NP	CD	O	26	NMOD	O
O	O	O	258	259	-	-	B-ADJP	HYPH	O	5	NMOD	O
O	O	O	259	260	(	(	O	(	O	15	DEP	O
O	O	O	260	261	5	5	B-NP	CD	O	14	NMOD	O
O	O	O	261	262	-	-	I-NP	HYPH	O	14	NMOD	O
O	O	O	262	279	chloronaphthalene	chloronaphthalene	I-NP	NN	B-DNA	14	NMOD	B-DNA
O	O	O	279	280	-	-	B-NP	HYPH	I-DNA	12	P	I-DNA
O	O	O	280	281	1	1	I-NP	CD	I-DNA	10	NMOD	I-DNA
O	O	O	281	282	-	-	I-NP	HYPH	O	14	P	O
O	O	O	282	290	sulfonyl	sulfonyl	I-NP	NN	O	15	DEP	O
O	O	O	290	291	)	)	O	)	O	5	NMOD	O
O	O	O	291	292	-	-	B-NP	HYPH	O	26	NMOD	O
O	O	O	292	294	1H	1H	I-NP	NN	O	26	NMOD	O
O	O	O	294	295	-	-	O	HYPH	O	26	NMOD	O
O	O	O	295	304	hexahydro	hexahydro	B-NP	AFX	B-cell_type	21	NMOD	B-cell_type
O	O	O	304	305	-	-	I-NP	HYPH	O	21	P	O
O	O	O	305	306	1	1	I-NP	CD	O	26	NMOD	O
O	O	O	306	307	,	,	I-NP	,	O	26	P	O
O	O	O	307	308	4	4	I-NP	CD	O	26	NMOD	O
O	O	O	308	309	-	-	I-NP	HYPH	O	26	NMOD	O
O	O	O	309	318	diazepine	diazepine	I-NP	NN	O	26	NMOD	O
O	O	O	319	332	hydrochloride	hydrochloride	I-NP	NN	O	34	NMOD	O
O	O	O	333	334	(	(	O	(	O	31	DEP	O
O	O	O	334	336	ML	ML	B-NP	NN	B-protein	30	NMOD	B-protein
O	O	O	336	337	-	-	O	HYPH	I-protein	30	P	I-protein
O	O	O	337	338	9	9	B-NP	CD	I-protein	31	DEP	I-protein
O	O	O	338	339	)	)	O	)	O	26	NMOD	O
O	O	O	339	340	,	,	O	,	O	34	P	O
O	O	O	341	343	an	an	B-NP	DT	O	34	NMOD	O
O	O	O	344	353	inhibitor	inhibitor	I-NP	NN	O	41	SUB	O
O	O	O	354	356	of	of	B-PP	IN	O	34	NMOD	O
O	O	O	357	363	myosin	myosin	B-NP	NN	B-protein	39	NMOD	B-protein
O	O	O	364	369	light	light	I-NP	JJ	I-protein	39	NMOD	I-protein
O	O	O	370	375	chain	chain	I-NP	NN	I-protein	39	NMOD	I-protein
O	O	O	376	382	kinase	kinase	I-NP	NN	I-protein	35	PMOD	I-protein
O	O	O	382	383	,	,	O	,	O	34	P	O
O	O	O	384	391	induces	induce	B-VP	VBZ	O	4	SBAR	O
O	O	O	392	407	differentiation	differentiation	B-NP	NN	O	41	OBJ	O
O	O	O	408	410	of	of	B-PP	IN	O	42	NMOD	O
O	O	O	411	421	monocytoid	monocytoid	B-NP	JJ	B-cell_line	47	NMOD	B-cell_line
O	O	O	422	430	leukemia	leukemia	I-NP	NN	I-cell_line	47	NMOD	I-cell_line
O	O	O	431	435	cell	cell	I-NP	NN	I-cell_line	47	NMOD	I-cell_line
O	O	O	436	441	lines	line	I-NP	NNS	I-cell_line	43	PMOD	I-cell_line
O	O	O	442	446	U937	U937	B-NP	NN	B-cell_line	52	NMOD	B-cell_line
O	O	O	447	450	and	and	I-NP	CC	O	52	NMOD	O
O	O	O	451	454	THP	THP	I-NP	NN	B-cell_line	52	NMOD	B-cell_line
O	O	O	454	455	-	-	B-NP	HYPH	I-cell_line	52	P	I-cell_line
O	O	O	455	456	1	1	I-NP	CD	I-cell_line	47	NMOD	I-cell_line
O	O	O	457	460	but	but	B-PP	CC	O	43	PMOD	O
O	O	O	461	464	not	not	B-PP	RB	O	55	PMOD	O
O	O	O	465	467	of	of	I-PP	IN	O	43	PMOD	O
O	O	O	468	480	myeloblastic	myeloblastic	B-NP	JJ	B-cell_line	61	NMOD	B-cell_line
O	O	O	481	489	leukemic	leukemic	I-NP	JJ	I-cell_line	61	NMOD	I-cell_line
O	O	O	490	492	ML	ML	I-NP	NN	I-cell_line	61	NMOD	I-cell_line
O	O	O	492	493	-	-	B-NP	HYPH	I-cell_line	61	NMOD	I-cell_line
O	O	O	493	494	1	1	I-NP	CD	I-cell_line	61	NMOD	I-cell_line
O	O	O	495	499	cell	cell	I-NP	NN	I-cell_line	65	NMOD	I-cell_line
O	O	O	500	502	or	or	I-NP	CC	O	65	NMOD	O
O	O	O	503	518	erythroleukemia	erythroleukemia	I-NP	NN	B-cell_line	65	NMOD	B-cell_line
O	O	O	519	523	K562	K562	I-NP	NN	I-cell_line	65	NMOD	I-cell_line
O	O	O	524	529	cells	cell	I-NP	NNS	I-cell_line	55	PMOD	I-cell_line
O	O	O	529	530	.	.	O	.	O	2	P	O

O	O	O	531	533	In	In	B-PP	IN	O	8	VMOD	O
O	O	O	534	537	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	538	545	present	present	I-NP	JJ	O	4	NMOD	O
O	O	O	546	551	study	study	I-NP	NN	O	1	PMOD	O
O	O	O	551	552	,	,	O	,	O	8	P	O
O	O	O	553	555	we	we	B-NP	PRP	O	8	SUB	O
O	O	O	556	563	further	further	B-ADVP	RB	O	8	VMOD	O
O	O	O	564	572	analyzed	analyze	B-VP	VBD	O	0	ROOT	O
O	O	O	573	576	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	577	583	effect	effect	I-NP	NN	O	8	OBJ	O
O	O	O	584	586	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	587	589	ML	ML	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	589	590	-	-	O	HYPH	I-protein	14	P	I-protein
O	O	O	590	591	9	9	B-NP	CD	I-protein	11	PMOD	I-protein
O	O	O	592	594	in	in	B-PP	IN	O	10	NMOD	O
O	O	O	595	605	comparison	comparison	B-NP	NN	O	15	PMOD	O
O	O	O	606	610	with	with	B-PP	IN	O	10	NMOD	O
O	O	O	611	615	that	that	B-NP	DT	O	17	PMOD	O
O	O	O	616	618	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	619	620	1	1	B-NP	CD	O	26	NMOD	O
O	O	O	621	626	alpha	alpha	B-NP	SYM	O	26	NMOD	O
O	O	O	626	627	,	,	O	,	O	26	P	O
O	O	O	628	630	25	25	B-NP	CD	O	26	NMOD	O
O	O	O	630	631	-	-	I-NP	HYPH	O	26	NMOD	O
O	O	O	631	647	dihydroxyvitamin	dihydroxyvitamin	I-NP	NN	O	26	NMOD	O
O	O	O	648	650	D3	D3	I-NP	NN	O	32	NMOD	O
O	O	O	651	652	(	(	O	(	O	29	DEP	O
O	O	O	652	655	VD3	VD3	B-NP	NN	O	29	DEP	O
O	O	O	655	656	)	)	O	)	O	26	NMOD	O
O	O	O	657	658	a	a	B-NP	DT	O	32	NMOD	O
O	O	O	659	666	typical	typical	I-NP	JJ	O	32	NMOD	O
O	O	O	667	674	inducer	inducer	I-NP	NN	O	19	PMOD	O
O	O	O	675	677	of	of	B-PP	IN	O	32	NMOD	O
O	O	O	678	687	monocytic	monocytic	B-NP	JJ	O	35	NMOD	O
O	O	O	688	703	differentiation	differentiation	I-NP	NN	O	33	PMOD	O
O	O	O	703	704	.	.	O	.	O	8	P	O

O	O	O	705	707	ML	ML	B-NP	NN	B-protein	4	SUB	B-protein
O	O	O	707	708	-	-	B-NP	HYPH	I-protein	1	P	I-protein
O	O	O	708	709	9	9	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	O	710	717	induced	induce	I-NP	VBN	O	23	NMOD	O
O	O	O	718	727	nitroblue	nitroblue	I-NP	JJ	O	4	VMOD	O
O	O	O	728	739	tetrazolium	tetrazolium	I-NP	NN	O	5	AMOD	O
O	O	O	740	741	(	(	O	(	O	9	DEP	O
O	O	O	741	744	NBT	NBT	B-NP	NN	O	9	DEP	O
O	O	O	744	745	)	)	O	)	O	6	NMOD	O
O	O	O	745	746	-	-	O	HYPH	O	6	P	O
O	O	O	746	754	reducing	reduce	B-VP	VBG	O	6	NMOD	O
O	O	O	755	763	activity	activity	B-NP	NN	O	11	OBJ	O
O	O	O	764	766	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	767	771	U937	U937	B-NP	NN	B-cell_line	15	NMOD	B-cell_line
O	O	O	772	776	cell	cell	I-NP	NN	I-cell_line	13	PMOD	I-cell_line
O	O	O	777	781	more	more	B-ADVP	RBR	O	17	AMOD	O
O	O	O	782	789	rapidly	rapidly	I-ADVP	RB	O	11	VMOD	O
O	O	O	790	794	than	than	B-PP	IN	O	17	AMOD	O
O	O	O	795	798	VD3	VD3	B-NP	NN	O	18	SBAR	O
O	O	O	798	799	:	:	O	:	O	4	P	O
O	O	O	800	804	This	This	B-NP	DT	O	23	NMOD	O
O	O	O	805	820	differentiation	differentiation	I-NP	NN	O	23	NMOD	O
O	O	O	821	827	marker	marker	I-NP	NN	O	24	SUB	O
O	O	O	828	831	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	832	839	induced	induce	I-VP	VBN	O	24	VC	O
O	O	O	840	853	significantly	significantly	B-ADVP	RB	O	25	VMOD	O
O	O	O	854	859	after	after	B-PP	IN	O	25	VMOD	O
O	O	O	860	870	incubation	incubation	B-NP	NN	O	34	NMOD	O
O	O	O	871	875	with	with	B-PP	IN	O	28	NMOD	O
O	O	O	876	878	ML	ML	B-NP	NN	B-protein	29	PMOD	B-protein
O	O	O	878	879	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
O	O	O	879	880	9	9	I-NP	CD	I-protein	31	NMOD	I-protein
O	O	O	881	884	and	and	O	CC	O	34	NMOD	O
O	O	O	885	888	VD3	VD3	B-NP	NN	O	27	PMOD	O
O	O	O	889	892	for	for	B-PP	IN	O	34	NMOD	O
O	O	O	893	894	4	4	B-NP	CD	O	37	NMOD	O
O	O	O	895	900	hours	hour	I-NP	NNS	O	40	NMOD	O
O	O	O	901	904	and	and	O	CC	O	40	NMOD	O
O	O	O	905	906	1	1	B-NP	CD	O	40	NMOD	O
O	O	O	907	910	day	day	I-NP	NN	O	35	PMOD	O
O	O	O	910	911	,	,	O	,	O	25	P	O
O	O	O	912	924	respectively	respectively	B-ADVP	RB	O	25	VMOD	O
O	O	O	924	925	.	.	O	.	O	24	P	O

O	O	O	926	928	ML	ML	B-NP	NN	O	5	SUB	O
O	O	O	928	929	-	-	O	HYPH	O	1	P	O
O	O	O	929	930	9	9	B-NP	CD	O	1	NMOD	O
O	O	O	931	935	also	also	B-ADVP	RB	O	5	VMOD	O
O	O	O	936	943	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	O	944	949	alpha	alpha	B-NP	SYM	O	10	NMOD	O
O	O	O	949	950	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	O	950	958	naphthyl	naphthyl	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	959	966	acetate	acetate	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	O	967	975	esterase	esterase	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	976	977	(	(	O	(	O	13	DEP	O
O	O	O	977	981	ANAE	ANAE	B-NP	NN	B-protein	13	DEP	B-protein
O	O	O	981	982	)	)	O	)	O	10	NMOD	O
O	O	O	983	991	activity	activity	B-NP	NN	O	19	NMOD	O
O	O	O	991	992	,	,	O	,	O	19	P	O
O	O	O	993	1000	another	another	B-NP	DT	O	19	NMOD	O
O	O	O	1001	1010	monocytic	monocytic	I-NP	JJ	O	19	NMOD	O
O	O	O	1011	1026	differentiation	differentiation	I-NP	NN	O	19	NMOD	O
O	O	O	1027	1033	marker	marker	I-NP	NN	O	5	OBJ	O
O	O	O	1033	1034	,	,	O	,	O	5	P	O
O	O	O	1035	1039	more	more	B-ADVP	RBR	O	5	VMOD	O
O	O	O	1040	1047	rapidly	rapidly	I-ADVP	RB	O	21	AMOD	O
O	O	O	1048	1052	than	than	B-PP	IN	O	21	AMOD	O
O	O	O	1053	1056	VD3	VD3	B-NP	NN	O	23	SBAR	O
O	O	O	1056	1057	.	.	O	.	O	5	P	O

O	O	O	1058	1061	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	1062	1069	maximum	maximum	I-NP	JJ	O	3	NMOD	O
O	O	O	1070	1076	levels	level	I-NP	NNS	O	12	SUB	O
O	O	O	1077	1079	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	1080	1085	these	these	B-NP	DT	O	6	NMOD	O
O	O	O	1086	1093	markers	marker	I-NP	NNS	O	4	PMOD	O
O	O	O	1094	1101	induced	induce	B-VP	VBN	O	6	NMOD	O
O	O	O	1102	1104	by	by	B-PP	IN	O	7	VMOD	O
O	O	O	1105	1107	ML	ML	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	1107	1108	-	-	B-NP	HYPH	I-protein	8	PMOD	I-protein
O	O	O	1108	1109	9	9	I-NP	CD	I-protein	10	NMOD	I-protein
O	O	O	1110	1114	were	be	B-VP	VBD	O	40	VMOD	O
O	O	O	1115	1125	comparable	comparable	B-ADJP	JJ	O	12	PRD	O
O	O	O	1126	1128	to	to	B-PP	TO	O	13	AMOD	O
O	O	O	1129	1134	those	those	B-NP	DT	O	14	PMOD	O
O	O	O	1135	1142	induced	induce	B-VP	VBN	O	15	NMOD	O
O	O	O	1143	1145	by	by	B-PP	IN	O	16	VMOD	O
O	O	O	1146	1149	VD3	VD3	B-NP	NN	O	17	PMOD	O
O	O	O	1149	1150	,	,	O	,	O	40	P	O
O	O	O	1151	1154	but	but	O	CC	O	40	VMOD	O
O	O	O	1155	1160	after	after	B-PP	IN	O	40	VMOD	O
O	O	O	1161	1168	removal	removal	B-NP	NN	O	21	PMOD	O
O	O	O	1169	1171	of	of	B-PP	IN	O	22	NMOD	O
O	O	O	1172	1174	ML	ML	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	O	1174	1175	-	-	B-NP	HYPH	I-protein	23	PMOD	I-protein
O	O	O	1175	1176	9	9	I-NP	CD	I-protein	25	NMOD	I-protein
O	O	O	1177	1181	from	from	B-PP	IN	O	22	NMOD	O
O	O	O	1182	1185	the	the	B-NP	DT	O	29	NMOD	O
O	O	O	1186	1192	medium	medium	I-NP	NN	O	27	PMOD	O
O	O	O	1193	1195	by	by	B-PP	IN	O	22	NMOD	O
O	O	O	1196	1203	washing	wash	B-VP	VBG	O	30	PMOD	O
O	O	O	1204	1207	the	the	B-NP	DT	O	33	NMOD	O
O	O	O	1208	1213	cells	cell	I-NP	NNS	O	31	OBJ	O
O	O	O	1213	1214	,	,	O	,	O	40	P	O
O	O	O	1215	1218	the	the	B-NP	DT	O	36	NMOD	O
O	O	O	1219	1230	expressions	expression	I-NP	NNS	O	40	SUB	O
O	O	O	1231	1233	of	of	B-PP	IN	O	36	NMOD	O
O	O	O	1234	1240	theses	theses	B-NP	DT	O	39	NMOD	O
O	O	O	1241	1248	markers	marker	I-NP	NNS	O	37	PMOD	O
O	O	O	1249	1258	decreased	decrease	B-VP	VBD	O	0	ROOT	O
O	O	O	1259	1265	within	within	B-PP	IN	O	40	VMOD	O
O	O	O	1266	1267	4	4	B-NP	CD	O	43	NMOD	O
O	O	O	1268	1273	hours	hour	I-NP	NNS	O	41	PMOD	O
O	O	O	1274	1277	and	and	O	CC	O	40	VMOD	O
O	O	O	1278	1285	reached	reach	B-VP	VBD	O	40	VMOD	O
O	O	O	1286	1291	basal	basal	B-NP	JJ	O	47	NMOD	O
O	O	O	1292	1298	levels	level	I-NP	NNS	O	45	OBJ	O
O	O	O	1299	1301	in	in	B-PP	IN	O	45	VMOD	O
O	O	O	1302	1303	1	1	B-NP	CD	O	50	NMOD	O
O	O	O	1304	1307	day	day	I-NP	NN	O	48	PMOD	O
O	O	O	1307	1308	,	,	O	,	O	40	P	O
O	O	O	1309	1319	indicating	indicate	B-VP	VBG	O	40	VMOD	O
O	O	O	1320	1324	that	that	B-SBAR	IN	O	52	VMOD	O
O	O	O	1325	1327	ML	ML	B-NP	NN	O	59	NMOD	O
O	O	O	1327	1328	-	-	B-NP	HYPH	O	59	NMOD	O
O	O	O	1328	1329	9	9	I-NP	CD	O	59	NMOD	O
O	O	O	1329	1330	'	'	I-NP	SYM	O	59	NMOD	O
O	O	O	1330	1331	s	s	I-NP	NN	O	59	NMOD	O
O	O	O	1332	1341	induction	induction	I-NP	NN	O	67	SUB	O
O	O	O	1342	1344	of	of	B-PP	IN	O	59	NMOD	O
O	O	O	1345	1355	expression	expression	B-NP	NN	O	60	PMOD	O
O	O	O	1356	1358	of	of	B-PP	IN	O	61	NMOD	O
O	O	O	1359	1374	differentiation	differentiation	B-NP	NN	O	66	NMOD	O
O	O	O	1374	1375	-	-	B-NP	HYPH	O	66	NMOD	O
O	O	O	1375	1385	associated	associate	I-NP	VBN	O	66	NMOD	O
O	O	O	1386	1396	phenotypes	phenotype	I-NP	NNS	O	62	PMOD	O
O	O	O	1397	1400	was	be	B-VP	VBD	O	53	SBAR	O
O	O	O	1401	1411	reversible	reversible	B-ADJP	JJ	O	67	PRD	O
O	O	O	1411	1412	.	.	O	.	O	40	P	O

O	O	O	1413	1416	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	1417	1423	growth	growth	I-NP	NN	O	3	NMOD	O
O	O	O	1424	1434	inhibition	inhibition	I-NP	NN	O	11	SUB	O
O	O	O	1435	1437	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	1438	1442	U937	U937	B-NP	NN	B-cell_line	6	NMOD	B-cell_line
O	O	O	1443	1448	cells	cell	I-NP	NNS	I-cell_line	4	PMOD	I-cell_line
O	O	O	1449	1451	by	by	B-PP	IN	O	3	NMOD	O
O	O	O	1452	1454	ML	ML	B-NP	NN	O	7	PMOD	O
O	O	O	1454	1455	-	-	B-NP	HYPH	O	8	P	O
O	O	O	1455	1456	9	9	I-NP	CD	O	8	NMOD	O
O	O	O	1457	1460	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1461	1465	also	also	B-ADVP	RB	O	11	VMOD	O
O	O	O	1466	1476	reversible	reversible	B-ADJP	JJ	O	11	PRD	O
O	O	O	1476	1477	.	.	O	.	O	11	P	O

O	O	O	1478	1485	Similar	Similar	B-NP	JJ	O	2	NMOD	O
O	O	O	1486	1493	effects	effect	I-NP	NNS	O	3	SUB	O
O	O	O	1494	1498	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1499	1507	observed	observe	I-VP	VBN	O	3	VC	O
O	O	O	1508	1510	in	in	B-PP	IN	O	4	VMOD	O
O	O	O	1511	1518	another	another	B-NP	DT	O	7	NMOD	O
O	O	O	1519	1523	line	line	I-NP	NN	O	15	NMOD	O
O	O	O	1524	1526	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	1527	1532	human	human	B-NP	JJ	B-cell_type	11	NMOD	B-cell_type
O	O	O	1533	1544	monoblastic	monoblastic	I-NP	JJ	I-cell_type	11	NMOD	I-cell_type
O	O	O	1545	1550	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	I-cell_type
O	O	O	1550	1551	,	,	O	,	O	14	P	O
O	O	O	1552	1555	THP	THP	B-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	1555	1556	-	-	B-NP	HYPH	I-cell_line	15	P	I-cell_line
O	O	O	1556	1557	1	1	I-NP	CD	I-cell_line	5	PMOD	I-cell_line
O	O	O	1557	1558	.	.	O	.	O	3	P	O

O	O	O	1559	1561	ML	ML	B-NP	NN	O	4	SUB	O
O	O	O	1561	1562	-	-	O	HYPH	O	1	P	O
O	O	O	1562	1563	9	9	B-NP	CD	O	1	NMOD	O
O	O	O	1564	1567	had	have	B-VP	VBD	O	0	ROOT	O
O	O	O	1568	1574	little	little	B-NP	JJ	O	8	NMOD	O
O	O	O	1575	1577	or	or	I-NP	CC	O	8	NMOD	O
O	O	O	1578	1580	no	no	I-NP	DT	O	8	NMOD	O
O	O	O	1581	1587	effect	effect	I-NP	NN	O	4	OBJ	O
O	O	O	1588	1590	on	on	B-PP	IN	O	4	VMOD	O
O	O	O	1591	1594	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	1595	1605	morphology	morphology	I-NP	NN	O	9	PMOD	O
O	O	O	1606	1608	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	1609	1613	U937	U937	B-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	1614	1619	cells	cell	I-NP	NNS	I-cell_line	12	PMOD	I-cell_line
O	O	O	1620	1623	but	but	O	CC	O	4	VMOD	O
O	O	O	1624	1633	increased	increase	B-VP	VBD	O	4	VMOD	O
O	O	O	1634	1637	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	1638	1648	expression	expression	I-NP	NN	O	16	OBJ	O
O	O	O	1649	1651	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	1652	1660	monocyte	monocyte	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	O	1660	1661	-	-	O	HYPH	I-protein	27	NMOD	I-protein
O	O	O	1661	1671	macrophage	macrophage	B-NP	NN	I-protein	23	NMOD	I-protein
O	O	O	1672	1679	lineage	lineage	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	O	1679	1680	-	-	B-VP	HYPH	I-protein	27	NMOD	I-protein
O	O	O	1680	1690	associated	associate	B-NP	VBN	I-protein	27	NMOD	I-protein
O	O	O	1691	1698	surface	surface	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	O	1699	1706	antigen	antigen	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	O	1706	1707	,	,	O	,	O	29	P	O
T1	B-Protein	B-Protein	1708	1712	CD14	CD14	B-NP	NN	B-protein	19	PMOD	B-protein
O	O	O	1712	1713	,	,	O	,	O	29	P	O
O	O	O	1714	1716	to	to	B-PP	TO	O	18	NMOD	O
O	O	O	1717	1721	some	some	B-NP	DT	O	33	NMOD	O
O	O	O	1722	1728	extent	extent	I-NP	NN	O	31	PMOD	O
O	O	O	1728	1729	.	.	O	.	O	4	P	O

O	O	O	1730	1742	Irreversible	Irreversible	B-NP	JJ	O	3	NMOD	O
O	O	O	1743	1751	terminal	terminal	I-NP	JJ	O	3	NMOD	O
O	O	O	1752	1767	differentiation	differentiation	I-NP	NN	O	7	SUB	O
O	O	O	1768	1775	induced	induce	B-VP	VBN	O	3	NMOD	O
O	O	O	1776	1778	by	by	B-PP	IN	O	4	VMOD	O
O	O	O	1779	1782	VD3	VD3	B-NP	NN	B-protein	5	PMOD	B-protein
O	O	O	1783	1785	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1786	1796	associated	associate	I-VP	VBN	O	7	NMOD	O
O	O	O	1797	1801	with	with	B-PP	IN	O	8	VMOD	O
O	O	O	1802	1806	down	down	B-NP	JJ	O	11	NMOD	O
O	O	O	1807	1817	regulation	regulation	I-NP	NN	O	20	NMOD	O
O	O	O	1818	1820	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	1821	1824	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	1825	1835	expression	expression	I-NP	NN	O	12	PMOD	O
O	O	O	1836	1838	of	of	B-PP	IN	O	14	NMOD	O
T2	B-Protein	B-Protein	1839	1840	c	c	B-NP	NN	B-DNA	18	NMOD	B-DNA
T2	I-Protein	I-Protein	1840	1841	-	-	I-NP	HYPH	I-DNA	18	NMOD	I-DNA
T2	I-Protein	I-Protein	1841	1844	myc	myc	I-NP	NN	I-DNA	15	PMOD	I-DNA
O	O	O	1845	1848	and	and	I-NP	CC	O	20	NMOD	O
O	O	O	1849	1861	upregulation	upregulation	I-NP	NN	O	9	PMOD	O
O	O	O	1862	1864	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	1865	1868	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	1869	1879	expression	expression	I-NP	NN	O	21	PMOD	O
O	O	O	1880	1882	of	of	B-PP	IN	O	23	NMOD	O
T3	B-Protein	B-Protein	1883	1884	c	c	B-NP	NN	B-DNA	27	NMOD	B-DNA
T3	I-Protein	I-Protein	1884	1885	-	-	I-NP	HYPH	I-DNA	27	NMOD	I-DNA
T3	I-Protein	I-Protein	1885	1888	fos	fos	I-NP	NN	I-DNA	31	NMOD	I-DNA
O	O	O	1889	1892	and	and	I-NP	CC	O	31	NMOD	O
T4	B-Protein	B-Protein	1893	1894	c	c	I-NP	NN	B-DNA	31	NMOD	B-DNA
T4	I-Protein	I-Protein	1894	1895	-	-	O	HYPH	I-DNA	31	P	I-DNA
T4	I-Protein	I-Protein	1895	1898	jun	jun	B-NP	NN	I-DNA	36	NMOD	I-DNA
O	O	O	1898	1899	,	,	O	,	O	36	P	O
O	O	O	1900	1903	but	but	O	CC	O	36	NMOD	O
O	O	O	1904	1906	ML	ML	B-NP	NN	O	36	NMOD	O
O	O	O	1906	1907	-	-	O	HYPH	O	34	P	O
O	O	O	1907	1908	9	9	B-NP	CD	O	24	PMOD	O
O	O	O	1909	1912	did	do	B-VP	VBD	O	7	VMOD	O
O	O	O	1913	1916	not	not	I-VP	RB	O	37	VMOD	O
O	O	O	1917	1923	affect	affect	I-VP	VB	O	37	VC	O
O	O	O	1924	1927	the	the	B-NP	DT	O	41	NMOD	O
O	O	O	1928	1938	expression	expression	I-NP	NN	O	39	OBJ	O
O	O	O	1939	1941	of	of	B-PP	IN	O	41	NMOD	O
O	O	O	1942	1947	these	these	B-NP	DT	O	44	NMOD	O
O	O	O	1948	1957	oncogenes	oncogene	I-NP	NNS	B-DNA	42	PMOD	B-DNA
O	O	O	1958	1969	appreciably	appreciably	B-ADVP	RB	O	39	VMOD	O
O	O	O	1969	1970	.	.	O	.	O	7	P	O

O	O	O	1971	1973	ML	ML	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	1973	1974	-	-	B-NP	HYPH	I-protein	1	P	I-protein
O	O	O	1974	1975	9	9	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	O	1975	1976	-	-	I-NP	HYPH	O	1	P	O
O	O	O	1976	1983	induced	induce	I-NP	VBN	O	6	NMOD	O
O	O	O	1984	1999	differentiation	differentiation	I-NP	NN	O	7	SUB	O
O	O	O	2000	2003	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	2004	2008	also	also	B-ADVP	RB	O	7	VMOD	O
O	O	O	2009	2019	reversible	reversible	B-ADJP	JJ	O	7	PRD	O
O	O	O	2020	2024	when	when	B-ADVP	WRB	O	7	VMOD	O
O	O	O	2025	2028	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	2029	2034	cells	cell	I-NP	NNS	O	13	SUB	O
O	O	O	2035	2039	were	be	B-VP	VBD	O	10	SBAR	O
O	O	O	2040	2048	cultured	culture	I-VP	VBN	O	13	VC	O
O	O	O	2049	2053	with	with	B-PP	IN	O	14	VMOD	O
O	O	O	2054	2062	cultured	culture	B-VP	VBN	O	15	PMOD	O
O	O	O	2063	2067	with	with	B-PP	IN	O	16	VMOD	O
O	O	O	2068	2070	ML	ML	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	2070	2071	-	-	O	HYPH	I-protein	20	P	I-protein
O	O	O	2071	2072	9	9	B-NP	CD	I-protein	26	NMOD	I-protein
O	O	O	2073	2077	plus	plus	O	CC	O	26	NMOD	O
O	O	O	2078	2080	an	an	B-NP	DT	O	26	NMOD	O
O	O	O	2081	2085	anti	anti	I-NP	AFX	O	26	NMOD	O
O	O	O	2085	2086	-	-	I-NP	HYPH	O	26	NMOD	O
O	O	O	2086	2092	cancer	cancer	I-NP	NN	O	26	NMOD	O
O	O	O	2093	2097	drug	drug	I-NP	NN	O	17	PMOD	O
O	O	O	2098	2102	such	such	B-PP	JJ	O	28	PMOD	O
O	O	O	2103	2105	as	as	I-PP	IN	O	26	NMOD	O
O	O	O	2106	2107	1	1	B-NP	CD	O	39	NMOD	O
O	O	O	2107	2108	-	-	O	HYPH	O	31	P	O
O	O	O	2108	2112	beta	beta	B-NP	SYM	O	39	NMOD	O
O	O	O	2112	2113	-	-	B-NP	HYPH	O	39	NMOD	O
O	O	O	2113	2114	D	D	I-NP	NN	O	39	NMOD	O
O	O	O	2114	2115	-	-	B-NP	HYPH	O	39	NMOD	O
O	O	O	2115	2122	arabino	arabino	I-NP	AFX	O	39	NMOD	O
O	O	O	2122	2123	-	-	I-NP	HYPH	O	39	NMOD	O
O	O	O	2123	2140	furanosylcytosine	furanosylcytosine	I-NP	NN	O	39	NMOD	O
O	O	O	2141	2143	or	or	I-NP	CC	O	39	NMOD	O
O	O	O	2144	2154	daunomycin	daunomycin	I-NP	NN	O	28	PMOD	O
O	O	O	2154	2155	.	.	O	.	O	7	P	O

O	O	O	2156	2158	it	it	B-NP	PRP	O	2	SUB	O
O	O	O	2159	2165	became	become	B-VP	VBD	O	0	ROOT	O
O	O	O	2166	2178	irreversible	irreversible	B-ADJP	JJ	O	5	AMOD	O
O	O	O	2178	2179	,	,	O	,	O	5	P	O
O	O	O	2180	2187	however	however	B-ADVP	RB	O	2	PRD	O
O	O	O	2187	2188	,	,	O	,	O	5	P	O
O	O	O	2189	2193	upon	upon	B-PP	IN	O	5	AMOD	O
O	O	O	2194	2206	simultaneous	simultaneous	B-NP	JJ	O	9	NMOD	O
O	O	O	2207	2216	treatment	treatment	I-NP	NN	O	7	PMOD	O
O	O	O	2217	2221	with	with	B-PP	IN	O	9	NMOD	O
O	O	O	2222	2235	dexamethasone	dexamethasone	B-NP	NN	O	17	NMOD	O
O	O	O	2236	2239	and	and	O	CC	O	17	NMOD	O
T5	B-Protein	B-Protein	2240	2252	transforming	transform	B-VP	VBG	B-protein	17	NMOD	B-protein
T5	I-Protein	I-Protein	2253	2259	growth	growth	B-NP	NN	I-protein	17	NMOD	I-protein
T5	I-Protein	I-Protein	2260	2266	factor	factor	I-NP	NN	I-protein	17	NMOD	I-protein
T5	I-Protein	I-Protein	2266	2267	-	-	O	HYPH	I-protein	17	NMOD	I-protein
T5	I-Protein	I-Protein	2267	2271	beta	beta	B-NP	SYM	I-protein	10	PMOD	I-protein
T5	I-Protein	I-Protein	2272	2273	1	1	I-NP	CD	I-protein	17	NMOD	I-protein
O	O	O	2274	2275	(	(	O	(	O	24	DEP	O
T6	B-Protein	B-Protein	2275	2278	TGF	TGF	B-NP	NN	B-protein	22	NMOD	B-protein
T6	I-Protein	I-Protein	2278	2279	-	-	O	HYPH	I-protein	22	NMOD	I-protein
T6	I-Protein	I-Protein	2279	2283	beta	beta	B-NP	SYM	I-protein	24	DEP	I-protein
T6	I-Protein	I-Protein	2284	2285	1	1	I-NP	CD	I-protein	22	NMOD	I-protein
O	O	O	2285	2286	)	)	O	)	O	17	NMOD	O
O	O	O	2286	2287	,	,	O	,	O	17	P	O
O	O	O	2288	2293	which	which	B-NP	WDT	O	17	NMOD	O
O	O	O	2294	2297	did	do	B-VP	VBD	O	26	SBAR	O
O	O	O	2298	2301	not	not	I-VP	RB	O	27	VMOD	O
O	O	O	2302	2308	induce	induce	I-VP	VB	O	27	VC	O
O	O	O	2309	2324	differentiation	differentiation	B-NP	NN	O	29	OBJ	O
O	O	O	2325	2327	of	of	B-PP	IN	O	30	NMOD	O
O	O	O	2328	2332	U937	U937	B-NP	NN	B-cell_line	33	NMOD	B-cell_line
O	O	O	2333	2338	cells	cell	I-NP	NNS	I-cell_line	31	PMOD	I-cell_line
O	O	O	2339	2342	but	but	O	CC	O	27	VMOD	O
O	O	O	2343	2349	caused	cause	B-VP	VBD	O	27	VMOD	O
O	O	O	2350	2356	growth	growth	B-NP	NN	O	37	NMOD	O
O	O	O	2357	2363	arrest	arrest	I-NP	NN	O	35	OBJ	O
O	O	O	2364	2366	of	of	B-PP	IN	O	37	NMOD	O
O	O	O	2367	2370	the	the	B-NP	DT	O	40	NMOD	O
O	O	O	2371	2376	cells	cell	I-NP	NNS	O	38	PMOD	O
O	O	O	2377	2379	in	in	B-PP	IN	O	35	VMOD	O
O	O	O	2380	2383	the	the	B-NP	DT	O	46	NMOD	O
O	O	O	2384	2386	G0	G0	I-NP	NN	O	46	NMOD	O
O	O	O	2386	2387	/	/	B-NP	SYM	O	46	NMOD	O
O	O	O	2387	2389	G1	G1	I-NP	NN	O	46	NMOD	O
O	O	O	2390	2395	phase	phase	I-NP	NN	O	41	PMOD	O
O	O	O	2396	2398	of	of	B-PP	IN	O	46	NMOD	O
O	O	O	2399	2402	the	the	B-NP	DT	O	50	NMOD	O
O	O	O	2403	2407	cell	cell	I-NP	NN	O	50	NMOD	O
O	O	O	2408	2413	cycle	cycle	I-NP	NN	O	47	PMOD	O
O	O	O	2413	2414	.	.	O	.	O	2	P	O

O	O	O	2415	2420	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	2421	2428	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	2429	2436	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	2437	2441	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	2442	2444	ML	ML	B-NP	NN	B-protein	8	SUB	B-protein
O	O	O	2444	2445	-	-	O	HYPH	I-protein	5	NMOD	I-protein
O	O	O	2445	2446	9	9	B-NP	CD	I-protein	5	NMOD	I-protein
O	O	O	2447	2453	should	should	B-VP	MD	O	4	SBAR	O
O	O	O	2454	2456	be	be	I-VP	VB	O	8	VC	O
O	O	O	2457	2463	useful	useful	B-ADJP	JJ	O	9	PRD	O
O	O	O	2464	2467	for	for	B-PP	IN	O	10	AMOD	O
O	O	O	2468	2476	studying	study	B-VP	VBG	O	11	PMOD	O
O	O	O	2477	2480	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	2481	2491	mechanisms	mechanism	I-NP	NNS	O	12	OBJ	O
O	O	O	2492	2494	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	2495	2504	monocytic	monocytic	B-NP	JJ	O	17	NMOD	O
O	O	O	2505	2520	differentiation	differentiation	I-NP	NN	O	15	PMOD	O
O	O	O	2520	2521	.	.	O	.	O	3	P	O
